Levofloxacin elimination during albumin dialysis

International Journal of Artificial Organs

Volumn 26, Issue 4, 2003, Pages 358-359

  Bellmann, Romuald ^a   Egger, P ^a   Pechlaner, C ^a   Feistritzer, C ^a   Vogel, W ^a   Joannidis, M ^a   Wiedermann, C J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN;

ALBUMIN; LEVOFLOXACIN;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; CRIGLER NAJJAR SYNDROME; DIALYSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; EMBRYO; HEMOFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LIVER TRANSPLANTATION; METABOLITE; PNEUMONIA;

EID: 0037769829     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600412     Document Type: Letter

References (6)

1. Novelli G, Rossi M, Pretagostini R, et al. Use of MARS in the treatment of acute liver failure: Preliminar monocentric experience. Transplant Proc 2001; 33: 1942-4.
2. Stange J, Mitzner SR, Klammt S, et al. Liver support by extracorporeal blood purification: A clinical observation. Liver Transpl 2000; 6: 603-13.
3. Hansen E, Bucher M, Jakob W, Lemberger P, Kees F. Pharmacokinetics of levofloxacin during veno-venous hemofiltration. Intens Care Med 2001; 27: 371-5.
4. Traunmüller F, Thalhammer-Scherrer R, Locker G, et al. Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients. J Antimicrob Chemother 2001; 47: 229-31.
5. Bellmann R, Egger P, Gritsch W, et al. Elimination of levofloxacin in critically ill patients with renal failure: Influence of continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther 2002; 40: 142-9.
6. Majcher-Peszynska J, Peszynski P, Klammt S, et al. Elimination of antibiotics by albumin dialysis. Pharmacol Toxicol 2001; 89 (suppl. 1). S88.